Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy

• Main Authors: Lui, Y.Y.N., Tsoi, K.K.F., Wong, V.W.S., Kao, J.H., Hou, J.L., Teo, E.K., Mohamed, R., Piratvisuth, T., Han, K.H., Mihm, U., Wong, G.L.H., Chan, H.L.Y.
• Format: Article
• Published: International Medical Press 2010
• Subjects: R Medicine
• Online Access: http://eprints.um.edu.my/15321/

Background: The roadmap approach is recommended to guide chronic hepatitis B treatment. We evaluated the cost-effectiveness of various treatment strategies in the global market. Methods: Lamivudine and telbivudine were tested in roadmap models with switch-to tenofovir if HBV was detectable at week 2...